M. Kishimoto

Detection of mutations in the human insulin gene by single strand conformation polymorphisms.

Y. Yazaki, M. Kasuga, T. Kadowaki, 1992, The Journal of clinical endocrinology and metabolism.

Polymorphism in exon 4a of the human GLUT4/ muscle-fat facilitative glucose transporter gene detected by SSCP.

Y. Yazaki, G. Bell, J. Buse, 1991, Nucleic acids research.

Histamine suppression of the non‐immunological release of slow reacting substances from neutrophils of asthmatics

S. Torii, M. Yamada, M. Kishimoto, 1983 .

The CD5+ B cells and myasthenia gravis.

T. Takenaka, S. Araga, K. Takahashi, 1995, Autoimmunity.

HTLV‐1‐associated myelopathy (HAM) with OKT4 epitope deficiency

M. Kishimoto, 1990, Acta neurologica Scandinavica.

Dot microfiltration sandwich EIA for the measurement of IGM concentrations in cerebrospinal fluid.

S. Araga, K. Takahashi, M. Kishimoto, 1989, Autoimmunity.

Mutations and deletions of the CBP gene in human lung cancer.

Tokuki Sakiyama, Jun Yokota, Takashi Kohno, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Treatment for the decline of ionized calcium levels during peripheral blood progenitor cell harvesting

S. Takenoshita, H. Ohto, A. Kikuta, 2002, Transfusion.

A complementary peptide vaccine that induces T cell anergy and prevents experimental allergic neuritis in Lewis rats.

S. Araga, K. Nakashima, M. Kishimoto, 1999, Journal of immunology.

Experimental Allergic Neuritis in Lewis Rats Induces T Cell Anergy and Prevents A Complementary Peptide Vaccine That

M. Kishimoto, S. Doi, Nakashima Shigeru Araga, 1999 .

Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.

S. Araga, F. Galin, J. Blalock, 1996, Journal of immunology.